Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023

LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today...

Related Keywords

Belgium ,Leuven ,Region Flamande ,Poland ,Sweden ,Gasthuisberg ,Stockholm ,Warsaw ,L67 ,Belgian ,Van Cutsem ,Eric Van Cutsem ,Phderic Van Cutsem ,Dominique Tersago ,David Liberg ,Prnewswire Cantargia ,University Hospitals Gasthuisberg ,Vp Research ,Belgian Foundation ,University Of Warsaw ,Nasdaq Stockholm ,Division Head ,Digestive Oncology ,Eric Van ,Medical University ,Prof Van Cutsem ,Belgian Royal Academy ,